SHould You TransFer the Tubercle?
SHYFT
A Randomized Clinical Pilot Trial Comparing Isolated Medial Patellofemoral Ligament Reconstruction to Medial Patellofemoral Ligament Reconstruction Combined with Tibial Tubercle Osteotomy: SHould You TransFer the Tubercle (SHYFT)?
1 other identifier
interventional
32
1 country
1
Brief Summary
The aim of this study is to investigate the role of tibial tubercle osteotomy (TTO) on the subjective and objective outcomes following medial patellofemoral ligament reconstruction (MPFL-R) in patients with an increased tibial tubercle-trochlear groove (TT-TG) distance with or without patella alta. This Pilot RCT will assess the feasibility of conducting this study for:
- 1.The ability to recruit study patients
- 2.Adherence to the study protocol
- 3.Completion rates of patient follow-up at a minimum of 12 months post-operative
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
March 8, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedFebruary 4, 2025
January 1, 2025
2.3 years
February 17, 2023
January 31, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Study Feasibility - patient recruitment
Number of study patients recruited
12-months post-operative
Study Feasibility - protocol adherence
Adherence to the study protocol (total number of protocol deviations)
12-months post-operative
Study Feasibility - follow-up completion
Number of patients completing follow-up a minimum of 12 months post-operative
12-months post-operative
Secondary Outcomes (6)
Banff Patellofemoral Instability Instrument (BPII 2.0)
Baseline, and 6-,12- & 24-months post-operative
Functional Outcomes - Hop Testing
6-, 12- & 24-months post-operative
Patellar Apprehension Test
6-, 12- & 24-months post-operative
Complications
6-, 12- & 24-months post-operative
Post-operative Knee Pain
6-, 12- & 24-months post-operative
- +1 more secondary outcomes
Study Arms (2)
MPFL-R
ACTIVE COMPARATORMedial patellofemoral ligament reconstruction
MPFL-R + TTO
ACTIVE COMPARATORMedial patellofemoral ligament reconstruction with concomitant tibial tubercle osteotomy
Interventions
Medial patellofemoral ligament reconstruction
Eligibility Criteria
You may qualify if:
- Age 13-30 years
- Symptomatic recurrent lateral patellofemoral instability
- TT-TG ≥15mm measured on MRI or ≥18mm on CT scan
- Closed physes (confirmed on knee x-rays)
You may not qualify if:
- Caton-Deschamps ratio ≥ 1.4 on lateral radiographs
- Femoral anteversion ≥ 25 degrees on diagnostic imaging rotational profile
- Tibial external rotation ≥ 45 degrees on diagnostic imaging rotational profile
- High-grade trochlear dysplasia requiring trochleoplasty
- Significant osteoarthritis on skyline plain imaging (Kellgren Lawrence grade ≥ 2)
- A chondral lesion of the patellofemoral joint that is undergoing a cartilage restoration procedure.
- Unable to complete computer-based outcome questionnaires
- Pregnant (at time of surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Banff Sport Medicine Foundationlead
- Canadian Orthopaedic Foundationcollaborator
- CONMED Corporationcollaborator
Study Sites (1)
Banff Sport Medicine
Canmore, Alberta, T1W 0L5, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Laurie A Hiemstra, MD, PhD
University of Calgary
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2023
First Posted
March 8, 2023
Study Start
September 1, 2023
Primary Completion
December 31, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
February 4, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share